The process of aging causes functional decline of the hematopoietic system, including reduced capacity for regeneration, increased risk of infections, and increased risk of certain forms of blood cancer. This is a significant health concern due to the worldwide increase in the age of the population and incidence of these age-related conditions. No intervention therapies currently exist to prevent functional decline of the hematopoietic system with aging, largely due to a lack of understanding of the cellular and molecular alterations that occur at the age of onset to cause functional hematopoietic decline. As hematopoietic stem cells assure long-term tissue maintenance, it is widely accepted based on experimental evidence that loss of proper hematopoietic stem cell function in the bone marrow during aging is a major cause of hematopoietic decline. Our preliminary data demonstrate that at the age of onset of functional hematopoietic decline, alterations in the bone marrow microenvironment are necessary and sufficient to cause hematopoietic stem cell aging, and identify reduced levels of the signaling molecule Insulin-like Growth Factor 1 (IGF-1) in the bone marrow as a candidate driver of hematopoietic stem cell aging. This project will use cellular and molecular biological approaches in aging mice to characterize the specific cellular and molecular alterations in the aging bone marrow microenvironment and how these cause functional decline of hematopoietic stem cells, including the specific cell type(s) responsible for reduced production of IGF-1 and how reduced IGF-1-mediated signaling drives functional decline of hematopoietic stem cells. Results of this project will reveal the mechanisms causing functional decline of the hematopoietic system with aging, and identify targeted, molecular- and cell type-specific therapeutic strategies to preserve regenerative capacity and immune cell function during aging.

Public Health Relevance

Aging is a complex process that contributes to reduced function in tissues throughout the body, including the blood system. The impact of aging on human health is of increasing societal concern due to the worldwide increase in age of our population. As no therapies currently exist to prevent aging of the blood system, there is a vital need to understand when and how proper function of the blood system begins to fail during aging. This research will provide important information that can be used to develop precision therapies to prevent this decline in function and sustain a healthy and robust blood system during aging.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
High Priority, Short Term Project Award (R56)
Project #
Application #
Study Section
Molecular and Cellular Hematology Study Section (MCH)
Program Officer
Bishop, Terry Rogers
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Jackson Laboratory
Bar Harbor
United States
Zip Code